MyAverix Finance
CO · Healthcare
Pharma Equity Group A/S Cl A (PEG)
Biotechnology
Pharma Equity Group A/S Cl A (PEG) is listed on CO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PEG
Pharma Equity Group A/S Cl A (PEG) — FAQ
What is PEG's P/E ratio?
The price-to-earnings (P/E) ratio for Pharma Equity Group A/S Cl A (PEG) is 18.00 (data as of 2026-03-22).
Does Pharma Equity Group A/S Cl A pay a dividend?
Dividend yield is not available in the current snapshot for Pharma Equity Group A/S Cl A (PEG). Check the MyAverix Finance app for the latest dividend data.
What sector is Pharma Equity Group A/S Cl A in?
Pharma Equity Group A/S Cl A (PEG) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PEG listed on?
PEG is listed on CO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.